company? Let’s change
that.
Don't see your company?
Create a company profileAt Elekta, our outcome-driven and cost-efficient solutions provide lasting clinical difference and are developed through sustainable environmental, social and governance practices. We’ve been working openly and proactively with clinicians and our partners for almost half a century to advance precision radiation therapy and meet continuously evolving patient needs—no matter where they are in the world. To us, it's personal, and our global team of 4,700 employees combine passion, science, and imagination to profoundly change cancer care. We don’t just build technology, we build hope. Elekta is headquartered in Stockholm, Sweden, with offices in 120 countries and listed on Nasdaq Stockholm.
GlucanBio, an early stage company that repurposes non-food biomass into high-value chemicals and biomaterials
Accuronix Therapeutics is a biotech company that develops drug targeting technology to resolve issues in cancer therapy.
Sling HealthTM (formerly IDEA Labs) is a student-run biotechnology incubator that provides resources, training, and mentorship to teams of students (medical, engineering, business, etc) tackling clinical problems by developing innovative solutions.
Digital health company with holographic AR platform for intraprocedural clinical use.
Confluence is a contract research organization providing mechanistic enzymology, target validation, characterization, and more.
Stereotaxis develops robotic cardiology instrument navigation systems that enhances the treatment of arrhythmias and coronary diseases.
NewLeaf Symbiotics develops and commercializes the bacteria found in Pink Pigmented Facultative Methylotrophs.
APT Therapeutics is a Biotechnology company located in 4041 Forest Park Ave., St. Louis, MO, United States.
PierianDx is catalyzing global adoption of genomic sequencing in healthcare
Adarza BioSystems develops a biological assay platform for measuring clinical and point-of-care samples.
BioSTL builds regional capacity and fosters collaborative efforts to advance innovation,
Readout is a sensor biomarker startup that enables sustained metabolic optimization of patients and self-care consumers with fat oxidation biofeedback in breath. We introduced Biosense in 2020 as a Class 1 medical device for in-home behavior modification. Our digital experience allows "dosing" of ketosis with a patented deep lung sampling technology in a precision nutrition journey from weight loss to healthspan in the palm of your hands.
As of September 2014, G-Biosciences management system governing the manufacture of our products is ISO9001:2008 certified. For more details on G-Biosciences biotechnology and life science research products click the products tab. Geno Technology, Inc. was founded in 1994 with a vision to simplify life science research. Our primary goal was to target the key techniques of protein research and find affordable methods to simplify and improve on these techniques. Over the years Geno Technology, Inc. has branched out into other areas of research, but our primary target still remains with proteins and our primary goal “simplify and improve on these techniques” still holds true. This message was reinforced in 2010 with the evolution of “The Protein Man”, our iconic mascot and the G-Biosciences brand. G-Biosciences’ team examined every aspect of particular experimental techniques, ranging from protein extraction to protein purification and detection, to identify key areas that we could target for improvement. As a result of this we now manufacture everything from simple buffers at convenient concentrations and sizes to custom manufactured devices, such as Tube-O-Dialyzer, that enhance and simplify key techniques. Our key areas we focused on included, but not limited to, protein assays, sample preparation, electrophoresis, Western blotting, mass spectrometry, assay development, antibody production and protein purification. G-Biosciences now offers thousands of products for the protein and life science research market, all designed with the hope of make a researcher’s lab time simpler and more affordable. Geno Biosciences Pvt. Ltd. is a division of Geno Technology, Inc. based in New Dehli, India. G-Biosciences, India is engaged in the distribution of the products manufactured by the parent company. Most recently supplementing G-Biosciences products with other leading manufacturers products to enhance the G-Biosciences inventory.
Tioma Therapeutics is a venture-stage biopharmaceutical company.
Intuitive Genomics helps customers to quickly uncover the vital insights and actionable information they need from their massive
Bacterioscan offers an instrument for detecting and quantifying bacteria in fluid with on-board incubation.
Pioneering Diagnostics A world leader in the field of in vitro diagnostics for over 55 years, bioMérieux is present in 44 countries and serves more than 160 countries with the support of a large network of distributors. In 2020, revenues reached €3.1 billion, with over 90% of sales outside of France. bioMérieux provides diagnostic solutions (systems, reagents, software, services) which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products. bioMérieux is listed on the Euronext Paris stock market.
Wugen is a developer of a novel CAR-T therapy platform intended for T-Cell Malignancies.
VaxNewMo is an early stage biotechnological company.
Work Your Passion. Live Your Purpose.